CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children

Name: CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
Published: 2020
License: Public Domain

City of Hope Medical Center · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

malignant brain neoplasm, recurrent malignant brain neoplasm, refractory malignant brain neoplasm, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children

Related documents